NTP 10th Report on Carcinogens. IARC Cancer Review: Animal Sufficient Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 4 , 1974,p. 127.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Community Right-To-Know List. Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program.

NIOSH REL: (Hydrazines) CL 0.04 mg/m³/2H

The Hydrazine sulfate (1:1) is an organic compound with the formula H₄N₂^.H₂SO₄. The IUPAC name of this chemical is hydrazine; sulfuric acid. With the CAS registry number 10034-93-2, it is also named as Diamidogen sulfate. The product's categories are Pharmaceutical Intermediates; Inorganics; ACS GradeOrganic Building Blocks; Essential Chemicals; Hydrazines; Nitrogen Compounds; Routine Reagents; Organic Building Blocks; Analytical Reagents for General Use; E-L, Puriss p.a. ACS; Puriss p.a. ACS. Besides, it is colourless crystal or white powder, which should be stored in a closed dry and well-ventilated place.

Physical properties about Hydrazine sulfate (1:1) are: (1)ACD/LogP: -1.03; (2)ACD/LogD (pH 5.5): -5.53; (3)ACD/LogD (pH 7.4): -5.53; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)#H bond acceptors: 4; (7)#H bond donors: 2; (8)Polar Surface Area: 60.98 Å²; (9)Enthalpy of Vaporization: 62.94 kJ/mol; (10)Boiling Point: 330 °C at 760 mmHg; (11)Vapour Pressure: 3.35E-05 mmHg at 25°C.

Preparation: this chemical can be prepared by urea, sodium hypochlorite, caustic soda. This reaction will need reagent sulfuric acid, catalyst potassium permanganate.

Uses of Hydrazine sulfate (1:1): it is a chemical compound that has been used as an alternative medical treatment for the loss of appetite (anorexia) and weight loss (cachexia) which is often associated with cancer. It has never been approved as a mainstream drug, although it is approved for use in clinical trials by the U.S. Food and Drug Administration (FDA) and is marketed in the United States as a dietary supplement. It is also sold over the internet by websites that promote its use as a cancer therapy. It is used in palliative care for terminal cancer patients in Russia and other countries of the former Soviet Union.

When you are using this chemical, please be cautious about it as the following:
It is toxic by inhalation, in contact with skin and if swallowed and very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. In case of accident or if you feel unwell seek medical advice immediately (show the label where possible). Besides, this chemical may cause sensitisation by skin contact and may cause cancer. Please avoid exposure - obtain special instructions before use. When you are using it, avoid release to the environment. Refer to special instructions/safety data sheet. This material and its container must be disposed of as hazardous waste.

You can still convert the following datas into molecular structure:
(1)SMILES: O=S(=O)(O)O.NN
(2)InChI: InChI=1/H4N2.H2O4S/c1-2;1-5(2,3)4/h1-2H2;(H2,1,2,3,4)
(3)InChIKey: ZGCHATBSUIJLRL-UHFFFAOYAL
(4)Std. InChI: InChI=1S/H4N2.H2O4S/c1-2;1-5(2,3)4/h1-2H2;(H2,1,2,3,4)
(5)Std. InChIKey: ZGCHATBSUIJLRL-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LDLo	oral	100mg/kg (100mg/kg)		"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935.
human	TDLo	oral	201mg/kg/8D (201mg/kg)	PERIPHERAL NERVE AND SENSATION: PARESTHESIS BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: NAUSEA OR VOMITING	Cancer Chemotherapy Reports, Part 1. Vol. 59, Pg. 1151, 1975.
mammal (species unspecified)	LC	inhalation	> 6400ug/m3 (6.4mg/m3)		Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. Vol. 28(12), Pg. 56, 1984.
mouse	LD50	intraperitoneal	152mg/kg (152mg/kg)	LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"	Archives of Environmental Health. Vol. 17, Pg. 315, 1968.
mouse	LD50	oral	434mg/kg (434mg/kg)		Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. Vol. 28(12), Pg. 56, 1984.
mouse	LD50	subcutaneous	455mg/kg (455mg/kg)		Acta Biologica et Medica Germanica. Vol. 21, Pg. 635, 1968.
rabbit	LDLo	oral	100mg/kg (100mg/kg)		"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935.
rat	LD50	intraperitoneal	230mg/kg (230mg/kg)		Russian Pharmacology and Toxicology Vol. 41, Pg. 74, 1978.
rat	LD50	oral	601mg/kg (601mg/kg)		"Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972Vol. -, Pg. 15, 1972.